RFICs
PRODUCTS
-
Antibody drug conjugates (ADCs) are the emerging class of anti-cancer therapeutic drugs. ADCs combine an antibody capable of recognizing cancer cells and cytotoxic small-molecule drugs via cleavable or non-cleavable linkers, thereby transforming the 3-unit combination into a targeted therapeutic drug for cancer treatment. In recent years, ADCs have rapidly developed and there are not only more than 14 approved drugs on the market but also many investigational drugs undergoing clinical trials. Furthermore, ADCs have shown potential for treating various diseases beyond cancer, such as Autoimmune disorders, Infectious diseases, Inflammatory conditions and so on.
-
The PTXM9754 is an ultra compact modular microwave power module (MPM) with an integrated “super mini” travelling wave tube (TWT), a solid state preamplifier and an optimised high density switch mode power supply.
-
Reduce microbiological organisms on equipment, in transfer chambers, in filling line isolators and more with Ecolab’s Bioquell IG-2, a robust, fixed bio-decontamination system.
-
Geospace Technologies offers a complete line of AMI water meter connector cables, specifically designed and manufactured to meet the rugged requirements for in-pit, underwater applications. Geospace’s unique design ensures total moisture sealing for even the toughest underwater environments, yet they are easily re-entered for troubleshooting a transponder or for a meter swap-out.
-
In the pharmaceutical industry, every capsule and tablet begins with a concept. Transforming that idea into a tangible product requires an expert manufacturing partner. Natoli stands out as a leader in pharmaceutical equipment and services, providing a comprehensive journey from formulation to full-scale production.
WHITE PAPERS AND CASE STUDIES
-
Manufacturing Transfers: Delivering 140+ Precision Medical Devices Without Missing A Deadline
Go inside a successful manufacturing transfer of over 140 Class-III silicone medical devices and on-time delivery for a top-30 OEM through expert project management and rigorous validation processes.
-
Cutting Costs, Not Corners: How PRI-TECH® Transformed Biosolids Odor Control At Bergen Point WWTP
The Suffolk County Department of Public Works tested the effectiveness and cost-efficiency of PRI-TECH® in controlling odors at a wastewater treatment plant. The technology successfully treated odors and reduced operating costs.
-
Boosting Recruitment Strategy For Phase III Study In Ulcerative Colitis
Learn about the successful execution of a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis despite strict inclusion criteria and a limited patient pool.
-
Accelerating A Complex Molecule From CLD To cGMP In 12 Months
Learn how to mitigate technical risk, implement parallel process development, and design custom purification strategies for highly sensitive novel modalities to accelerate to cGMP material.
-
Streamlined Facility Design: A Success Story
Examine how one medium-sized US company's need for a new aseptic compounding and fill-finish facility was addressed with a tailored solution within a challenging time-frame.
-
Leverage Apps To Reduce Line Changeover Time From 14 Days To 3
A global biopharma leader modernized its complex equipment changeover process using an innovative platform to achieve faster execution, fewer errors, and greater visibility through digitized, validatable SOPs.
-
AMERICAN SpiralWeld Pipe Delivers For City Of Phoenix Drought Pipeline Project
Phoenix’s Drought Pipeline Project, supported by AMERICAN SpiralWeld Pipe, secures clean water for North Phoenix, delivering up to 75 million gallons daily and earning top industry awards.
-
Accelerating Early Phase Oncology Study Development
Explore a close collaboration to co-develop a comprehensive, adaptive protocol designed to support key decisions across multiple trial phases for an innovative cancer therapy.
-
Yorkshire Water Reduces Leaks By 57%, Eliminating 30% Of Annual Distribution Main Repairs
Yorkshire Water Services (YWS) is a leading UK water utility that serves nearly 5.5 million people and has a well-deserved reputation as a progressive and proactive utility. Their belief that innovation is one of the key driving forces that allows utilities to deliver better services to their customers while keeping costs down has led them to always seek out new ways to improve their operations both now and in the future.
-
Drilling Down On Diversity And Feasibility
A mid-sized contract research organization (CRO) sought help with writing clinical trial diversity action plans and assessing feasibility for therapeutic areas outside its usual scope.
-
How We Used Intelligent Automation to Transform Vendor Selection
Discover how your small biotech can achieve faster timelines, improved cost control, and more strategic, transparent choices with a platform leveraging intelligent automation.
-
Scalable Production Of High-Purity Nanobodies Using Yeast Expression System
Leverage scalable K. pastoris expression systems to produce high-quality nanobodies for cutting-edge therapeutic, diagnostic, and research applications.
NEWS
-
Silo Pharma Expands Intellectual Property Portfolio With Patent Application For Exclusively Licensed Alzheimer's Drug4/28/2025
Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent application with the U.S. Patent and Trademark Office (USPTO) focused on the neurology drug SPC-14, an intranasal compound for the treatment of Alzheimer’s disease (AD) exclusively licensed to Silo Pharma from Columbia University.
-
Quantum Biopharma Announces Signing Of An Agreement With A Global Pharmaceutical Contract Research Organization To Prepare An IND (Investigational New Drug) Application Package For Lucid-21-302 (Lucid-MS), A First-In-Class Treatment For Multiple Sclerosis5/20/2025
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that it has signed an agreement with a global pharmaceutical contract research organization to prepare an IND (Investigational New Drug) application package for Lucid-21-302 (Lucid-MS) with the US FDA.
-
Puraffinity Signs First Commercial Agreement For Full-Scale Deployment Of Its PFAS Removal Technology6/2/2025
The agreement was signed with Envytech Solutions, the leading expert in mobile water treatment in the Nordic region and a member of the Sortera Group, which operates across the Nordics and the UK.
-
Dielectric Partners With Foccus Digital For Brazilian Broadcast Growth8/15/2025
Dielectric’s Brazilian presence is about to radiate stronger through a new partnership with Foccus Digital that expand Dielectric’s broadcast business throughout the country.
-
Drawing Inspiration From Ancient Chemical Reactions3/20/2025
To help find solutions to the planet’s climate crisis, MIT Associate Professor Daniel Suess is looking to Earth’s ancient past.
ABOUT
About Nutrient Removal
Nutrient removal from wastewater consists of treating wastewater to remove nitrogen and phosphorus before it reenters natural waterways. High levels of nitrogen and phosphorus in wastewater cause eutrophication, a process where excess nutrients stimulate excessive plant growth such as algal blooms and cyanobacteria. The decomposition of the algae by bacteria uses up the oxygen in the water causing other organisms to die. This creates more organic matter for the bacteria to decompose. In addition, some algal blooms can produce toxins that contaminate drinking water supplies.
As authorized by the Clean Water Act, the National Pollutant Discharge Elimination System (NPDES) permit program regulates point sources, such as municipal wastewater treatment plants, that discharge pollutants as effluent into the waters of the United States. In recent years, many of the States’ environmental bodies have lowered nutrient limits to arrest eutrophication. Maryland’s effort to protect the Chesapeake Bay and its tidal tributaries is perhaps the most notable example of nutrient removal in the US. Nutrient removal continues to be a growing area of focus for wastewater treatment throughout the world.
The removal of nitrogen and phosphorus require different nutrient removal processes. To remove nitrogen, the nitrogen is oxidized from ammonia to become nitrate through a process called nitrification. This process is then followed by denitrification where the nitrate is reduced to nitrogen gas which is released to the atmosphere and removed from the wastewater.
Nitrification is a two-step aerobic process which typically takes place in aeration tanks. Denitrification requires anoxic conditions to encourage the appropriate biological conditions to form. The activated sludge process is often used to reduce nitrate to nitrogen gas in anoxic or denitrification tanks.
Phosphorus can be removed biologically using polyphosphate accumulating organisms (PAOs) which accumulate large quantities of phosphorus within their cells and separate it from treated water. Phosphorus removal can also be achieved by chemical removal. Once removed as sludge, phosphorus may be stored in a land fill. However, many municipalities and treatment facilities are looking to resell the biosolids for use in fertilizer.